Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Inclusion Criteria: * Diagnosis of COPD according to GOLD guidelines * Post-bronchodilator 30%≤FEV1\<80% of predicted normal and ost-bronchodilator FEV1/FVC \<0.7 * Smoking history of at least 10 pack years Exclusion Criteria: * Requiring oxygen therapy on a daily basis * Exacerbation of airway disease in the 6 weeks prior to screening or between screening and dosing * Lung reduction surgery * Respiratory tract infection in the 6 weeks prior to screening * Significant cardiac history * History of asthma with onset of symptoms prior to age 40 years * Active use of certain COPD medications, beta blockers Other protocol-defined inclusion/exclusion criteria may apply